The absence of lipid- and blood pressure–lowering targets in the new CVD prevention guidelines represents a “missed opportunity” for optimal risk reduction, says a leading…
Patients with rheumatoid arthritis could be almost 50% more likely to develop aortic stenosis than those without the inflammatory condition, according to US doctors. Results…
Changes to CVD guidelines will benefit patients just below the high-risk threshold, but questions remain over the new percentage-based risk categories, says a leading GP. The RACGP-endorsed Australian CVD…
GPs now have access to revamped CVD prevention guidelines and a risk calculator, with the outdated Framingham-based equation officially consigned to the scrap heap. The…
Antiplatelet monotherapy with clopidogrel or ticagrelor may be safer and more effective for secondary prevention of cardiovascular events than aspirin alone, results from a large…
Over-60s with existing coronary heart disease have a higher risk of recurrent MI or angina in the presence of elevated lipoprotein(a) levels, results from a…
Showing patients images of their subclinical atherosclerosis can drive behavioural change and reduce their overall cardiovascular disease risk, Australian researchers report. Their systematic review suggests…
Testing for elevated lipoprotein(a) should be considered in all patients with premature cardiovascular disease and familial hypercholesterolaemia, according to the Australian Atherosclerosis Society. It also…
The RACGP has criticised a push for MBS-funded lipoprotein(a) testing to identify patients at elevated risk of heart disease, warning the proposal could be outdated…
Large study using UK data examines the risk of enzyme-inducing medications.
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
